Keyphrases
Vascular Permeability
100%
Pulmonary Arterial
100%
Urokinase-type Plasminogen Activator
100%
Arterial Contraction
100%
Vascular Contraction
23%
Contractility
23%
Catalytic Activity
23%
N-methyl-D-aspartate Receptor (NMDAR)
15%
Receptor 1
15%
Phenylephrine
15%
N-methyl-D-aspartate
15%
Arterial Ring
15%
Acute Lung Injury
7%
Fibrinolytic Activity
7%
Fibrin
7%
Dose Effect
7%
Pathological Conditions
7%
Low-density Lipoprotein Receptor
7%
Protein Receptor
7%
Physiological Concentrations
7%
Step Processes
7%
Selective Inhibition
7%
Evans Blue
7%
Pulmonary Blood Flow
7%
Pulmonary Vascular Permeability
7%
Docking Site
7%
Pulmonary Artery Smooth muscle Cells (PASMCs)
7%
Ligand-receptor Docking
7%
Biochemistry, Genetics and Molecular Biology
Muscle Contractility
100%
Blood Vessel Permeability
100%
Urokinase
100%
Enzymatic Activity
23%
Phenylephrine
15%
LDL Receptor
7%
Fibrinolysis
7%
Evans Blue
7%
Lung Blood Flow
7%
Lipoprotein Receptor-Related Protein
7%
N-Methyl-D-Aspartic Acid
7%
Immunology and Microbiology
Blood Vessel Permeability
100%
Muscle Contractility
100%
Vascular Smooth Muscle Cell
9%
Fibrinolysis
9%
Lung Blood Flow
9%
Low Density Lipoprotein Receptor Related Protein
9%
Pharmacology, Toxicology and Pharmaceutical Science
Urokinase
100%
Receptor
38%
Phenylephrine
15%
Injury
7%
Fibrinolytic Agent
7%
Acute Lung Injury
7%
N Methyl Dextro Aspartic Acid
7%
Evans Blue
7%
Extravasation
7%
Low Density Lipoprotein Receptor Related Protein
7%